Benchmark Investment Advisors’s National Health Investors NHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$404K Buy
+5,000
New +$416K 0.24% 59
2025
Q3
$398K Buy
+5,000
New +$374K 0.23% 59
2025
Q1
$369K Hold
5,000
0.24% 71
2024
Q4
$347K Hold
5,000
0.23% 69
2024
Q3
$420K Hold
5,000
0.3% 62
2024
Q2
$339K Hold
5,000
0.25% 70
2024
Q1
$314K Hold
5,000
0.25% 73
2023
Q4
$279K Hold
5,000
0.26% 73
2023
Q3
$257K Hold
5,000
0.26% 74
2023
Q2
$262K Hold
5,000
0.24% 79
2023
Q1
$258K Hold
5,000
0.26% 79
2022
Q4
$261K Hold
5,000
0.28% 86
2022
Q3
$283K Hold
5,000
0.3% 81
2022
Q2
$303K Hold
5,000
0.32% 82
2022
Q1
$295K Hold
5,000
0.22% 110
2021
Q4
$287K Buy
+5,000
New +$277K 0.24% 84

Other funds holding NHI

Benchmark Investment Advisors's NHI Position: Q1 2026 in Review

Benchmark Investment Advisors opened a new position in National Health Investors (NHI) in Q1 2026: 5,000 shares worth $404K. The stake represents 0.24% of the portfolio and ranks #59 among its holdings. This is a return to the name: Benchmark Investment Advisors previously reported a position in NHI as recently as Q3 2025.

Benchmark Investment Advisors first reported a position in NHI in Q4 2021 and has held it in 16 quarters since. The position peaked at $420K in Q3 2024. 318 funds tracked by Wall St. Rank hold NHI as of Q1 2026.

  • Benchmark Investment Advisors held 5,000 shares of National Health Investors worth $404K as of Q1 2026.
  • National Health Investors was a new Benchmark Investment Advisors position in Q1 2026.
  • National Health Investors made up 0.24% of Benchmark Investment Advisors's portfolio in Q1 2026, its #59 holding.
  • Benchmark Investment Advisors first reported a position in National Health Investors in Q4 2021 and has held it in 16 quarters since.
  • Benchmark Investment Advisors's National Health Investors position peaked at $420K in Q3 2024.
  • 318 funds tracked by Wall St. Rank held National Health Investors as of Q1 2026.

Based on Benchmark Investment Advisors's 13F filing for Q1 2026, filed 13 May 2026.